Illumina Competitors
| ILMN Stock | USD 116.38 2.94 2.46% |
Illumina vs Laboratory Correlation
Good diversification
The correlation between Illumina and LH is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Illumina and LH in the same portfolio, assuming nothing else is changed.
Moving together with Illumina Stock
At this time, Illumina's Return On Tangible Assets are very stable compared to the past year. As of the 12th of February 2026, Return On Capital Employed is likely to grow to 0.16, while Return On Assets are likely to drop 0.12. At this time, Illumina's Non Currrent Assets Other are very stable compared to the past year. As of the 12th of February 2026, Other Current Assets is likely to grow to about 249.9 M, while Total Assets are likely to drop about 4.2 B.Illumina Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Illumina and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Illumina and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Illumina does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Illumina Stock performing well and Illumina Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Illumina's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DGX | 1.18 | 0.25 | 0.15 | 1.68 | 0.91 | 2.75 | 6.29 | |||
| WAT | 1.20 | (0.27) | 0.00 | (0.15) | 0.00 | 3.25 | 18.00 | |||
| MEDP | 1.57 | (0.55) | 0.00 | (0.60) | 0.00 | 3.02 | 20.40 | |||
| ZBH | 1.13 | 0.05 | 0.02 | 0.16 | 1.17 | 2.92 | 7.20 | |||
| HOLX | 0.14 | 0.00 | (0.52) | 0.15 | 0.03 | 0.32 | 1.03 | |||
| THC | 1.70 | 0.13 | 0.05 | 0.29 | 1.63 | 3.14 | 15.98 | |||
| ICLR | 2.17 | (0.41) | 0.00 | (0.13) | 0.00 | 4.70 | 16.93 | |||
| WST | 1.58 | (0.31) | 0.00 | (0.09) | 0.00 | 2.76 | 12.18 | |||
| GMAB | 1.77 | (0.03) | (0.01) | 0.07 | 2.15 | 4.09 | 9.44 | |||
| LH | 1.03 | 0.21 | 0.15 | 0.55 | 0.83 | 2.85 | 5.89 |
Cross Equities Net Income Analysis
Compare Illumina and related stocks such as Quest Diagnostics, Waters, and Medpace Holdings Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DGX | (626 M) | 470.6 M | 555.7 M | 849 M | 556 M | 709 M | 645 M | 772 M | 736 M | 858 M | 1.4 B | 2 B | 946 M | 854 M | 871 M | 992 M | 646.9 M |
| WAT | 2 M | 433 M | 461.4 M | 450 M | 431.6 M | 469.1 M | 521.5 M | 20.3 M | 593.8 M | 592.2 M | 521.6 M | 692.8 M | 707.8 M | 642.2 M | 637.8 M | 642.6 M | 373.6 M |
| MEDP | 24.8 M | 24.8 M | 24.8 M | 24.8 M | (15.6 M) | (8.7 M) | 13.4 M | 39.1 M | 73.2 M | 100.4 M | 145.4 M | 181.8 M | 245.4 M | 282.8 M | 404.4 M | 451.1 M | 473.7 M |
| ZBH | 145 M | 760.8 M | 755 M | 761 M | 720.3 M | 147 M | 305.9 M | 1.8 B | (379.2 M) | 1.1 B | (138.9 M) | 401.6 M | 231.4 M | 1 B | 903.8 M | 705.2 M | 605.5 M |
| HOLX | 1.4 M | (73.6 M) | (1.2 B) | 17.3 M | 131.6 M | 330.8 M | 755.5 M | (111.3 M) | (40.2 M) | 1.1 B | 1.9 B | 1.3 B | 456 M | 789.5 M | 565.7 M | 650.6 M | 683.1 M |
| THC | 63 M | 82 M | 152 M | (134 M) | 12 M | (140 M) | (192 M) | (704 M) | 104 M | (215 M) | 399 M | 914 M | 411 M | 611 M | 3.2 B | 3.7 B | 3.9 B |
| ICLR | 3.9 M | 22.9 M | 55.4 M | 102.8 M | 172.5 M | 239.5 M | 262.2 M | 281.5 M | 322.8 M | 374 M | 327.8 M | 153.2 M | 505.3 M | 612.3 M | 791.5 M | 910.2 M | 955.7 M |
| WST | 15 M | 75.5 M | 80.7 M | 112.3 M | 127.1 M | 95.6 M | 143.6 M | 150.7 M | 206.9 M | 241.7 M | 346.2 M | 661.8 M | 585.9 M | 593.4 M | 492.7 M | 566.6 M | 594.9 M |
| GMAB | (479.3 M) | (596.4 M) | (487.1 M) | 112.4 M | 301.3 M | 763.5 M | 1.2 B | 1.1 B | 1.5 B | 2.2 B | 4.8 B | 3 B | 5.5 B | 4.4 B | 7.8 B | 9 B | 9.5 B |
| LH | 49.1 M | 519.7 M | 583.1 M | 573.8 M | 511.2 M | 436.9 M | 732.1 M | 1.3 B | 883.7 M | 823.8 M | 1.6 B | 2.4 B | 1.3 B | 418 M | 746 M | 857.9 M | 509.7 M |
Illumina and related stocks such as Quest Diagnostics, Waters, and Medpace Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Illumina financial statement analysis. It represents the amount of money remaining after all of Illumina operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Illumina Competitive Analysis
The better you understand Illumina competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Illumina's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Illumina's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Illumina Competition Performance Charts
Five steps to successful analysis of Illumina Competition
Illumina's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Illumina in relation to its competition. Illumina's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Illumina in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Illumina's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Illumina, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Illumina position
In addition to having Illumina in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run USD Crypto Fund Thematic Idea Now
USD Crypto Fund
Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Illumina Correlation with its peers. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.858 | Earnings Share 5.32 | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets |
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.